Supernus Pharmaceuticals
SUPN
#4477
Rank
NZ$3.25 B
Marketcap
$58.93
Share price
-15.47%
Change (1 day)
28.92%
Change (1 year)

Market capitalization of Supernus Pharmaceuticals (SUPN)

Market cap: NZ$3.25 Billion

As of February 2025 Supernus Pharmaceuticals has a market cap of NZ$3.25 Billion. This makes Supernus Pharmaceuticals the world's 4477th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Supernus Pharmaceuticals from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$3.25 B-10.61%
2024NZ$3.64 B45.61%
2023NZ$2.50 B-17.68%
2022NZ$3.03 B33.77%
2021NZ$2.27 B23.15%
2020NZ$1.84 B-0.36%
2019NZ$1.85 B-28.59%
2018NZ$2.59 B-9.92%
2017NZ$2.87 B59.28%
2016NZ$1.80 B87.65%
2015NZ$0.96 B111.39%
2014NZ$0.45 B24.09%
2013NZ$0.36 B37.46%
2012NZ$0.26 B

End of Day market cap according to different sources

On Feb 18th, 2025 the market cap of Supernus Pharmaceuticals was reported to be:

NZ$3.84 Billion
by Nasdaq info icon info icon
NZ$3.84 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$2.63 B-19.14%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$29.71 B 813.17%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.365 T 41,860.87%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$195.40 B 5,904.80%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$401.78 B 12,246.81%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$667.57 B 20,414.56%๐Ÿ‡บ๐Ÿ‡ธ USA